Though α5-null mutation causes embryonic lethality in mice (Yang et al., 1993), α5+/− mice are viable and display significant resistance to disturbed flow-induced EC dysfunction and atherosclerosis (Sun et al., 2016), suggesting a benefit from lowering α5 activities. This evidence concerns the gene IGKV2D-26 and atherosclerosis.